New England Journal of Medicine

Diseases, Conditions, Syndromes

Nirsevimab protects infants against RSV-linked hospitalization

Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England ...

page 8 from 40